Cancer Family

Urinary System Neoplasm

Non-malignant964 active trials28 approved drugs109 evidence items

NCIt: C3431

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (244)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 244 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Introducing "HEDGE": sequential intravesical gemcitabine-based thermochemotherapy (HIVEC) plus docetaxel as a potential novel bladder-sparing strategy for BCG-unresponsive non-muscle-invasive bladder cancer.
Lampros Mitrakas, Athanasios Zisopoulos, Konstantinos Dimitropoulos et al. · Arch Ital Urol Androl · Sep 25, 2026 · PMID 42714388 · candidate dictionary pubmed
Phenanthrene Derivatives from Arundina graminifolia Inhibit the Migration and Proliferation of Human Bladder Cancer Cells.
Xingyu Zhang, Songlin Yu, Shiquan Liu et al. · Anticancer Agents Med Chem · Sep 25, 2026 · PMID 42786873 · candidate dictionary pubmed
Re: Valentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al. Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol 2026;90:7-12.
Ahmed M Elalfy · Eur Urol · Sep 25, 2026 · PMID 42791106 · candidate dictionary pubmed
European epidemiology of kidney cancer.
Neriman Sıla Koç · Nephrol Dial Transplant · Sep 24, 2026 · PMID 42784442 · candidate dictionary pubmed
Simpler risk stratification and new options for recurrent low-grade disease: 2026 update to the AUA/SUO non-muscle invasive bladder cancer guideline.
David J Nusbaum, Scott M Gilbert, Roger Li · J Urol · Sep 24, 2026 · PMID 42784640 · candidate dictionary pubmed
Assessing Pathological Response to Neoadjuvant Therapy in Kidney Cancer: Quality over Quantity?
James O Jones, J C Koen van der Mijn, Axel Bex et al. · Eur Urol Oncol · Sep 23, 2026 · PMID 42778454 · candidate

dictionary

pubmed

Safety profile of BCG with or without immunotherapy in non-muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis.

C Ciccarese, D Occhipinti, P Troisi et al. · ESMO Open · Sep 23, 2026 · PMID 42777327 · candidate dictionary pubmed

GLG1 in cancer-associated fibroblasts promotes bladder cancer growth while limiting tumor apoptosis.

Jingpeng Liu, Zhongbao Zhou, Baining Zhang et al. · Apoptosis · Sep 23, 2026 · PMID 42776300 · candidate dictionary pubmed

Targeting LAMP2 synergizes with gemcitabine to inhibit bladder cancer progression via modulating STING degradation and regulating macrophage phenotypes.

Yue Lv, Qiang Yin, Wuheng Li et al. · Apoptosis · Sep 23, 2026 · PMID 42776282 · candidate dictionary pubmed

Enhanced NRF1-mediated proteasome bounce-back and nelfinavir-mediated bortezomib sensitization in gemcitabine/cisplatin-resistant bladder cancer cells.

Atsumi Ota, Mina Kawai, Rin Himura et al. · Biochem Biophys Res Commun · Sep 23, 2026 · PMID 42790027 · candidate dictionary pubmed

Associations of Anatomical Location and Reader Experience With the Diagnostic Performance of Multiparametric MRI-Derived VI-RADS for Muscle Invasive Bladder Cancer: A Multicenter Multireader Study.

Xiangyu Wang, Feng Sun, Jingjun Hu et al. · J Magn Reson Imaging · Sep 22, 2026 · PMID 42773621 · candidate dictionary pubmed

Editorial for "Associations of Anatomical Location and Reader Experience With the Diagnostic Performance of Multiparametric MRI-Derived VI-RADS for Muscle Invasive Bladder Cancer: A Multicenter Multireader Study".

Yoshiko Ueno, Keitaro Sofue, Takamichi Murakami · J Magn Reson Imaging · Sep 22, 2026 · PMID 42773585 · candidate dictionary pubmed

E2F3 amplification primes bladder cancer cells for premature mitosis.

Kathryn A Wierenga, Isabel S Nieland, Qingwu Liu et al. · Cancer Gene Ther · Sep 22, 2026 · PMID 42773250 · candidate dictionary pubmed

How Do I Treat the Very Elderly With Advanced Bladder Cancer as We Have so Many New Agents?

Ian D Davis · JCO Oncol Pract · Sep 22, 2026 · PMID 42771841 · candidate dictionary pubmed

Evaluation of thulium laser endoscopic en bloc resection versus conventional trans-urethral en bloc resection of primary non-muscle invasive bladder cancer: a randomized controlled trial.

Mohammed Mahmoud Zaza, Mohamed ElSayed ElAzab, Samuel Fayek Ebskharoun et al. · Int Urol Nephrol · Sep 22, 2026 · PMID 42771231 · candidate dictionary pubmed

Association between cervical human papillomavirus infection and bladder cancer risk: A community-based cohort study.

Peng-Tzu Liu, Wan-Lun Hsu, Tzu-I Chen et al. · J Infect Public Health · Sep 22, 2026 · PMID 42790347 · candidate dictionary pubmed

Exploring MV14 as a nitric oxide-releasing strategy for bladder cancer: From synthesis to in vivo evaluation.

Miriam López, María Varela, Mariana Ingold et al. · Eur J Med Chem · Sep 22, 2026 · PMID 42790168 · candidate dictionary pubmed

Emerging patterns of kidney cancer in young adults: where do we stand?

Paola Troisi, Denis Occhipinti, Chiara Ligato et al. · Crit Rev Oncol Hematol · Sep 20, 2026 · PMID 42764100 · candidate dictionary pubmed

Pentachlorophenol enhances bladder cancer cell invasion through altered protein stability.

Ranran Zhou, Wansong Zhang, Ming Xia et al. · iScience · Sep 18, 2026 · PMID 42699065 · candidate dictionary pubmed

Is This the End of the Cisplatin Eligibility Era in Muscle-invasive Bladder Cancer? Letter in reference to: Matthew D. Galsky, Begoña P. Valderrama, Marco Maruzzo, et al. Enfortumab vedotin and pembrolizumab in cisplatin-eligible bladder cancer. N Engl J Med 2026;395:338-48. doi:10.1056/NEJMoa2601486; and Galsky MD, Hahn NM, Rosenberg J, et al. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. Lancet Oncol 2011;12:211-214. doi:10.1016/S1470-2045(10)70275-8.

Patrizia Giannatempo, Linda Cerbone, Fabio Calabrò · Eur Urol · Sep 18, 2026 · PMID 42760245 · candidate dictionary pubmed

Radiomics and Deep Learning Models Based on Manual and Semi-automatic Segmentation of Ultrasound Images for HER2 Prediction in Bladder Cancer.

Jiajing Zhuang, Yihan Xie, Yuefan Chen et al. · Acad Radiol · Sep 18, 2026 · PMID 42760168 · candidate dictionary pubmed

Plasma cfDNA fragmentomics enables non-invasive detection and preoperative risk stratification of bladder cancer in a multicenter study.

Kaihua Liu, Hua Bao, Guangqi Li et al. · Cancer Lett · Sep 18, 2026 · PMID 42759922 · candidate dictionary pubmed

AXL drives immunotherapy resistance by modulating IL-17 in bladder cancer.

Wenlong Wan, Fang Wei, Lu Yang et al. · Biochem Pharmacol · Sep 18, 2026 · PMID 42759897 · candidate dictionary pubmed

Efficacy and safety analysis of disitamab vedotin combined with immunotherapy as neoadjuvant treatment to promote conversion to bladder preservation in bladder cancer: A retrospective comparative study with the GC combined with immunotherapy regimen.

Jing Li, Kaikai Chen, Shun Zhang et al. · Urol Oncol · Sep 18, 2026 · PMID 42759308 · candidate dictionary pubmed

Diagnostic value of CEUS-VI-RADS for predicting muscle invasion in bladder cancer: Validation of the scoring system and introduction of tumor-bladder wall contact length as a supplementary quantitative metric.

Wenhao Qu, Ju Zhu, Yahan Yang et al. · Urol Oncol · Sep 18, 2026 · PMID 42759306 · candidate dictionary pubmed